Live feed
Filing
SC 13G
SC 13G0001144204-15-049640·Aimmune Therapeutics, Inc.
Schedule 13G ownership disclosure
Aimmune Therapeutics, Inc.
Security class unavailable · CUSIP: 00900T107
Event date: 2015-08-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,087,900
- Percent of class
- 9.6900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-15-049640
- Form type
- SC 13G
- Filer
- Aimmune Therapeutics, Inc.
- CIK
- CIK 1631650
- Filed
- Aug 14, 2015
- Reporting period
- Aug 06, 2015
- Description
- Schedule 13G beneficial ownership